Monoclonal Gammopathy of Undetermined Significance (MGUS) Does Not Affect Outcomes in Patients Undergoing Solid Transplants.
Jimenez-Zepeda V, Heilman R, Mulligan D, Stewart A. Monoclonal Gammopathy of Undetermined Significance (MGUS) Does Not Affect Outcomes in Patients Undergoing Solid Transplants. Blood 2009, 114: 2834. DOI: 10.1182/blood.v114.22.2834.2834.Peer-Reviewed Original ResearchB-cell malignanciesMGUS patientsTransplant outcomesMonoclonal gammopathyActive myelomaUndetermined significanceSolid transplantsGeneral populationCell malignanciesExact testMonoclonal B-cell malignancySolid organ transplant patientsDevelopment of MGUSIncidence of MGUSNon-transplant populationPresence of MGUSLong-term followOrgan transplant patientsDiagnosis of MGUSMayo Clinic ArizonaFisher's exact testDifferentiated plasma cellsPancreatic transplantsChronic immunosuppressionTransplant patients